Search research articles
Contact Us
Filters
Showing results (191-200 of 248) with videos related to
Page
of 25
Sort By:
Cancer Research and Treatment
|
March 4, 2017
S-1-Induced Lacrimal Drainage Obstruction and Its Association with Ingredients/Metabolites of S-1 in Tears and Plasma: A Prospective Multi-institutional Study
Namju Kim, Jin Won Kim, Je-Hyun Baek, et al.
The Oncologist
|
March 13, 2020
Talazoparib in Patients with a Germline BRCA-Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial
Sara A Hurvitz, Anthony Gonçalves, Hope S Rugo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 27, 2007
ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer
Kyung-Hun Lee, Hye Sook Min, Sae-Won Han, et al.
Journal of Breast Cancer
|
April 3, 2015
Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
Taeryung Kim, Wonshik Han, Min Kyoon Kim, et al.
Journal of the National Cancer Institute
|
May 17, 2019
Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population
Ching-Hung Lin, Yoon Sim Yap, Kyung-Hun Lee, et al.
Cancer Research and Treatment
|
March 4, 2017
Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors
Koung Jin Suh, Se Hyun Kim, Kyung-Hun Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2022
Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer
Joanne L Blum, A Douglas Laird, Jennifer K Litton, et al.
The Lancet. Gastroenterology & Hepatology
|
March 12, 2022
Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study
Do-Youn Oh, Kyung-Hun Lee, Dae-Won Lee, et al.
Journal of Cancer Research and Clinical Oncology
|
November 19, 2015
Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy
Hyori Kim, Jeonghwan Youk, Yaewon Yang, et al.
Journal of Liver Cancer
|
January 21, 2024
Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis
Jeayeon Park, Yun Bin Lee, Yunmi Ko, et al.
Page
of 25
Search research articles
Search
Showing results (191-200 of 248) with videos related to
Sort By:
Page
of 25
Cancer Research and Treatment
|
March 4, 2017
S-1-Induced Lacrimal Drainage Obstruction and Its Association with Ingredients/Metabolites of S-1 in Tears and Plasma: A Prospective Multi-institutional Study
Namju Kim, Jin Won Kim, Je-Hyun Baek, et al.
The Oncologist
|
March 13, 2020
Talazoparib in Patients with a Germline BRCA-Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial
Sara A Hurvitz, Anthony Gonçalves, Hope S Rugo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 27, 2007
ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer
Kyung-Hun Lee, Hye Sook Min, Sae-Won Han, et al.
Journal of Breast Cancer
|
April 3, 2015
Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
Taeryung Kim, Wonshik Han, Min Kyoon Kim, et al.
Journal of the National Cancer Institute
|
May 17, 2019
Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population
Ching-Hung Lin, Yoon Sim Yap, Kyung-Hun Lee, et al.
Cancer Research and Treatment
|
March 4, 2017
Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors
Koung Jin Suh, Se Hyun Kim, Kyung-Hun Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2022
Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer
Joanne L Blum, A Douglas Laird, Jennifer K Litton, et al.
The Lancet. Gastroenterology & Hepatology
|
March 12, 2022
Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study
Do-Youn Oh, Kyung-Hun Lee, Dae-Won Lee, et al.
Journal of Cancer Research and Clinical Oncology
|
November 19, 2015
Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy
Hyori Kim, Jeonghwan Youk, Yaewon Yang, et al.
Journal of Liver Cancer
|
January 21, 2024
Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis
Jeayeon Park, Yun Bin Lee, Yunmi Ko, et al.
Page
of 25